Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy-Reference-Cited by-同舟云学术

Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy

Published:2023-12-19 Issue:12 Volume:12 Page:17
ISSN:2164-2591
Container-title:Translational Vision Science & Technology
language:en
Short-container-title:Trans. Vis. Sci. Tech.

Author:

Carosielli Marianna¹,Carnevali Adriano²,Fallico Matteo³,Pirozzi Enza⁴,Chiosi Flavia⁵,Chronopoulos Argyrios⁶,Cucciniello Pasquale¹,Affatato Marzia¹,Rapino Giuseppe¹,dell'Omo Roberto¹,

Affiliation:

1. Department of Medicine and Health Sciences “Vincenzo Tiberio”, University of Molise, Campobasso, Italy

2. Department of Ophthalmology, University Magna Græcia, Catanzaro, Italy

3. Department of Ophthalmology, University of Catania, Catania, Italy

4. Department of Ophthalmology, Santa Croce e Carle Hospital, Cuneo, Italy

5. Department of Ophthalmology, Azienda Ospedaliera dei Colli-Ospedale Monaldi, Naples, Italy

6. Department of Ophthalmology, Ludwigshafen Hospital, Ludwigshafen am Rhein, Germany

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

Ophthalmology,Biomedical Engineering

Reference27 articles.

1. Pachychoroid diseases of the macula;Gallego-Pinazo;Med Hypothesis Discov Innov Ophthalmol,2014

2. Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy;Mrejen;Ophthalmology,2019

3. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration;Fung;Retina,2012

4. Pachychoroid neovasculopathy;Pang;Retina,2015

5. Pachychoroid disease;Cheung;Eye,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of brolucizumab on diabetic macular edema and ischemia; a real world analysis;2024-08-16

2. Effectiveness and safety of brolucizumab in the treatment of neovascular age-related macular degeneration;Russian Annals of Ophthalmology;2024